Article
Lipoprotein(a) and coronary heart disease.
Chemistry and physics of lipids - 1 Jan 1994
Rodriguez C R, Seman L J, Ordovas J M, Jenner J, Genest M S, Wilson P W, Schaefer E J
Abstract excerpt
Elevated plasma or serum lipoprotein(a) (Lp(a)) levels have been associated with premature coronary heart disease (CHD). Lp(a) levels can be assessed quantitatively by electrophoresis and quantitatively by immunoassays determining either total Lp(a) mass, apo(a) mass on Lp(a) protein mass, or by precipitation methods followed by measurement of Lp(a) cholesterol. We prefer the latter method because it can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
